Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
Holders of 5% or more of ONCR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oncorus, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Oncorus, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Oncorus, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | CHI Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | Arkin Moshe | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2023 | Flynn James E | 13D/AOld format | – | – | – | SEC |
| Jan 17, 2023 | Flynn James E | 13D/AOld format | – | – | – | SEC |
| Jan 3, 2023 | Flynn James E | 13D/AOld format | – | – | – | SEC |
| Dec 22, 2022 | Flynn James E | 13D/AOld format | – | – | – | SEC |
| Nov 1, 2022 | K2 HealthVentures Equity Trust LLC | 13GOld format | – | New | – | SEC |
| Jul 8, 20224:56 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 15, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | CHI Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Dec 2, 2021 | Arkin Moshe | 13GOld format | – | New | – | SEC |
| Mar 2, 2021 | CHI Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Oncorus, Inc. shares.
No Form 144 notices for Oncorus, Inc. are on file.